Moleculin Biotech Inc.
1.83
-0.08 (-4.19%)
At close: Jan 15, 2025, 3:59 PM
1.85
1.09%
After-hours Jan 15, 2025, 04:09 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -29.77M -29.02M -15.89M -17.36M -13.21M -11.88M -9.80M -3.93M -748.36K
Depreciation & Amortization 127.00K 130.00K 164.00K 200.00K 199.00K 68.00K 18.00K 6.16K n/a
Stock-Based Compensation 1.98M 2.27M 2.37M 1.68M 1.54M 1.14M 707.00K 411.47K n/a
Other Working Capital 1.22M -507.00K 803.00K 983.00K -3.05M 1.17M 131.00K 40.87M 322.79K
Other Non-Cash Items 1.94M -1.24M 96.00K 85.00K 476.00K -3.15M 2.60M 423.80K 2.06K
Deferred Income Tax n/a n/a -6.73M -2.34M -4.06M n/a -1.39M n/a n/a
Change in Working Capital 1.62M 224.00K 1.04M -41.00K -2.14M 1.61M 542.00K -256.18K 322.79K
Operating Cash Flow -24.10M -27.64M -18.95M -17.77M -17.20M -12.20M -7.32M -3.76M -423.51K
Capital Expenditures -124.00K -67.00K -19.00K -376.00K -52.00K -417.00K -28.00K -21.47K n/a
Acquisitions n/a n/a n/a 2.00K 1K n/a n/a -99.64K n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a 2.00 1.00 n/a n/a n/a n/a
Investing Cash Flow -124.00K -67.00K -19.00K -374.00K -51.00K -417.00K -28.00K -121.11K n/a
Debt Repayment n/a n/a n/a n/a n/a n/a n/a -304.94K 450.00K
Common Stock Repurchased n/a -23 n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 485.00K -23.00K 40.00K -12.00K 1.56M 20.00K 3.99M -61 n/a
Financial Cash Flow 4.65M -23.00K 74.72M 22.55M 20.85K 12.04M 10.06M 8.87M 451.60K
Net Cash Flow -19.59M -27.76M 55.73M 4.44M 3.60M -580.00K 2.71M 4.98M 28.09K
Free Cash Flow -24.23M -27.71M -18.97M -18.15M -17.25M -12.62M -7.35M -3.79M -423.51K

Create Price Alert on MBRX

Your price alert will notify you when the stock price is above 1.83.

Add to Watchlist